
TransMedics Group TMDX
$ 99.05
-3.08%
Annual report 2025
added 02-24-2026
TransMedics Group DPO Ratio 2011-2026 | TMDX
Annual DPO Ratio TransMedics Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.5 | 23.4 | 33.5 | 64.7 | 158 | 171 | 272 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 272 | 15.5 | 105 |
Quarterly DPO Ratio TransMedics Group
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.1 | 17.2 | - | 24.9 | 22.5 | 27.1 | - | 35.2 | 33 | 27.4 | - | 18.6 | 21.7 | 116 | - | 145 | 65 | 50.8 | - | 53.6 | 74.3 | 144 | - | 221 | 283 | 260 | - | 226 | 248 | 135 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 283 | 15.1 | 98.5 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
Xtant Medical Holdings
XTNT
|
55.7 | $ 0.55 | -2.31 % | $ 73.5 M | ||
|
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | ||
|
Zimmer Biomet Holdings
ZBH
|
50.4 | $ 88.57 | -0.65 % | $ 18 B | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
Alphatec Holdings
ATEC
|
73.8 | $ 10.93 | -5.12 % | $ 1.64 B | ||
|
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
49.2 | $ 0.4 | 4.21 % | $ 41.1 M | ||
|
Insulet Corporation
PODD
|
22.5 | $ 208.22 | -4.53 % | $ 14.6 B | ||
|
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
CONMED Corporation
CNMD
|
57.3 | $ 34.58 | -5.62 % | $ 1.07 B | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
32.2 | - | - | $ 1.08 M | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
125 | $ 0.59 | -1.18 % | $ 32.1 M | ||
|
Aethlon Medical
AEMD
|
61.8 | $ 2.15 | -5.29 % | $ 3.36 M | ||
|
Edwards Lifesciences Corporation
EW
|
58.1 | $ 79.34 | -3.36 % | $ 46.4 B | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
43.9 | $ 11.2 | -1.84 % | $ 1.51 B | ||
|
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.52 | -5.08 % | $ 364 M | ||
|
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
1.22 K | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
34.8 | $ 0.7 | 2.32 % | $ 29.3 M | ||
|
Penumbra
PEN
|
26.1 | $ 335.1 | -0.39 % | $ 13 B | ||
|
Inspire Medical Systems
INSP
|
103 | $ 50.13 | -0.63 % | $ 1.47 B | ||
|
Pulmonx Corporation
LUNG
|
60.4 | $ 1.17 | -5.65 % | $ 47.6 M | ||
|
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
124 | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
19.8 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
61.7 | - | - | $ 217 M | ||
|
Surgalign Holdings
SRGA
|
78.4 | - | -32.98 % | $ 1.68 M | ||
|
STRATA Skin Sciences
SSKN
|
79.2 | - | - | $ 6.6 M | ||
|
AVITA Medical
RCEL
|
532 | $ 3.82 | -1.04 % | $ 106 M | ||
|
AxoGen
AXGN
|
34.4 | $ 31.28 | -3.01 % | $ 1.44 B |